{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:38:36Z","timestamp":1780544316165,"version":"3.54.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.clinbiochem.2026.111106","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:10:53Z","timestamp":1771546253000},"page":"111106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Elevated IL-27 and altered anti-inflammatory cytokine levels in SLE patients with end-stage renal disease"],"prefix":"10.1016","volume":"143","author":[{"given":"Paria","family":"Bayati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa Hussein","family":"Neamah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Sadani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoo","family":"Emtiazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Saeidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Ghorbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Amirkhanlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111106_b0005","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12882-020-01915-5","article-title":"Comparison of clinical features and outcomes between patients with early and delayed lupus nephritis","volume":"21","author":"Ahn","year":"2020","journal-title":"BMC Nephrol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2026.111106_b0010","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2215\/CJN.10601016","article-title":"Clinical and histopathologic characteristics associated with renal outcomes in lupus nephritis","volume":"12","author":"Rijnink","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111106_b0015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clinbiochem.2026.111106_b0020","doi-asserted-by":"crossref","unstructured":"Mocellin S, Panelli MC, Wang E, Rossi CR, Marincola FM. The dual role of IL-10. Trends Immunol. 2004;25(1):36-43.","DOI":"10.1016\/S1471-4906(02)00009-1"},{"issue":"7","key":"10.1016\/j.clinbiochem.2026.111106_b0025","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.3390\/ijms26073290","article-title":"IL-10 in systemic lupus erythematosus: balancing immunoregulation and autoimmunity","volume":"26","author":"Richter","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111106_b0030","first-page":"1","article-title":"IL-10 in kidney disease: from pathogenesis to therapeutic potential","volume":"31","author":"Sun","year":"2018","journal-title":"J. Nephrol."},{"key":"10.1016\/j.clinbiochem.2026.111106_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108917","article-title":"The role of IL-10 in kidney disease","volume":"108","author":"Wei","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.clinbiochem.2026.111106_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.970906","article-title":"IL-10 revisited in systemic lupus erythematosus","volume":"13","author":"Biswas","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111106_b0045","doi-asserted-by":"crossref","first-page":"34604","DOI":"10.1038\/srep34604","article-title":"Clinical associations of IL-10 and IL-37 in systemic lupus erythematosus","volume":"6","author":"Godsell","year":"2016","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.clinbiochem.2026.111106_b0050","doi-asserted-by":"crossref","first-page":"F596","DOI":"10.1152\/ajprenal.00365.2015","article-title":"TGF-\u03b2 signaling in the kidney: profibrotic and protective effects","volume":"310","author":"Sureshbabu","year":"2016","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111106_b0055","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clinbiochem.2026.111106_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00123","article-title":"Diverse role of TGF-\u03b2 in kidney disease","volume":"8","author":"Gu","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111106_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010408","article-title":"Fibrosis in chronic kidney disease: pathogenesis and consequences","volume":"22","author":"Panizo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clinbiochem.2026.111106_b0070","doi-asserted-by":"crossref","unstructured":"Meng X-M. Inflammatory mediators and renal fibrosis. Renal Fibrosis: Mechanisms and Therapies. 2019:381-406.","DOI":"10.1007\/978-981-13-8871-2_18"},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111106_b0075","doi-asserted-by":"crossref","first-page":"5672","DOI":"10.3390\/ijms24065672","article-title":"The role of IL-13 and IL-4 in adipose tissue fibrosis","volume":"24","author":"Arndt","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"45","key":"10.1016\/j.clinbiochem.2026.111106_b0080","doi-asserted-by":"crossref","first-page":"19420","DOI":"10.1073\/pnas.1005793107","article-title":"IL-27 structural analysis demonstrates similarities with ciliary neurotrophic factor (CNTF) and leads to the identification of antagonistic variants","volume":"107","author":"Rousseau","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.clinbiochem.2026.111106_b0085","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.4049\/jimmunol.1100106","article-title":"Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis","volume":"188","author":"Liu","year":"2012","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2026.111106_b0090","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.4049\/jimmunol.175.4.2191","article-title":"A role for IL-27 in early regulation of Th1 differentiation","volume":"175","author":"Owaki","year":"2005","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111106_b0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4049\/jimmunol.176.1.237","article-title":"IL-27 limits IL-2 production during Th1 differentiation","volume":"176","author":"Villarino","year":"2006","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.clinbiochem.2026.111106_b0100","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.autrev.2015.08.001","article-title":"IL-27-induced modulation of autoimmunity and its therapeutic potential","volume":"14","author":"Meka","year":"2015","journal-title":"Autoimmun. Rev."},{"issue":"8","key":"10.1016\/j.clinbiochem.2026.111106_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108433","article-title":"An IL-27-driven transcriptional network identifies regulators of il-10 expression across t helper cell subsets","volume":"33","author":"Zhang","year":"2020","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.clinbiochem.2026.111106_b0110","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/ni1376","article-title":"Interleukin 27 negatively regulates the development of interleukin 17\u2013producing T helper cells during chronic inflammation of the central nervous system","volume":"7","author":"Stumhofer","year":"2006","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.clinbiochem.2026.111106_b0115","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1002\/eji.200737810","article-title":"IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells","volume":"37","author":"Niedbala","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clinbiochem.2026.111106_b0120","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev-immunol-032414-112134","article-title":"The immunobiology of interleukin-27","volume":"33","author":"Yoshida","year":"2015","journal-title":"Annu. Rev. Immunol."},{"issue":"19","key":"10.1016\/j.clinbiochem.2026.111106_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914883","article-title":"Characterization of serum cytokine profiles of patients with active lupus nephritis","volume":"24","author":"Rahm\u00e9","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clinbiochem.2026.111106_b0130","doi-asserted-by":"crossref","DOI":"10.1177\/2058738419863238","article-title":"Regulatory T-cells and their impacts on cytokine profile of end-stage renal disease patients suffering from systemic lupus erythematosus","volume":"33","author":"Fathi","year":"2019","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2026.111106_b0135","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3389\/fimmu.2015.00550","article-title":"Pathogenic inflammation and its therapeutic targeting in systemic lupus erythematosus","volume":"6","author":"Gottschalk","year":"2015","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.clinbiochem.2026.111106_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/biom11070928","article-title":"Clinical and immunological biomarkers for systemic lupus erythematosus","volume":"11","author":"Yu","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111106_b0145","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12865-020-00388-3","article-title":"Assessing the expression of immunosuppressive cytokines in the newly diagnosed systemic lupus erythematosus patients: a focus on B cells","volume":"21","author":"Abbasifard","year":"2020","journal-title":"BMC Immunol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111106_b0150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/err.err_15_17","article-title":"Correlation of serum interleukin-10 level with disease activity and severity in systemic lupus erythematosus","volume":"45","author":"Abd Elazeem","year":"2018","journal-title":"Egypt. Rheumatol. Rehabil."},{"issue":"12","key":"10.1016\/j.clinbiochem.2026.111106_b0155","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1177\/0961203315585815","article-title":"Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus","volume":"24","author":"Cai","year":"2015","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.clinbiochem.2026.111106_b0160","first-page":"2867","article-title":"Changes of serum IL-6, IL-10 and TNF-\u03b1 levels in patients with systemic lupus erythematosus and their clinical value","volume":"13","author":"Jin","year":"2021","journal-title":"Am. J. Transl. Res."},{"issue":"8","key":"10.1016\/j.clinbiochem.2026.111106_b0165","doi-asserted-by":"crossref","first-page":"852","DOI":"10.2174\/1871530322666220304214512","article-title":"Serum cytokine levels of systemic lupus erythematosus patients in the presence of concomitant cardiovascular diseases","volume":"22","author":"Melamud","year":"2022","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111106_b0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejr.2013.10.003","article-title":"The role of interleukins 4, 17 and interferon gamma as biomarkers in patients with Systemic Lupus Erythematosus and their correlation with disease activity","volume":"36","author":"Elewa","year":"2014","journal-title":"The Egypt. Rheumatol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111106_b0175","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0272-6386(12)80979-6","article-title":"Interleukin-4 expression in mesangial proliferative glomerulonephritis","volume":"23","author":"Okada","year":"1994","journal-title":"Am. J. Kidney Dis."},{"issue":"21","key":"10.1016\/j.clinbiochem.2026.111106_b0180","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.81836","article-title":"B cell\u2013derived IL-4 acts on podocytes to induce proteinuria and foot process effacement","volume":"2","author":"Kim","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.clinbiochem.2026.111106_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.623944","article-title":"Epstein Barr virus and autoimmune responses in systemic lupus erythematosus","volume":"11","author":"Jog","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111106_b0190","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/eji.201546095","article-title":"A novel IL-23p19\/Ebi3 (IL-39) cytokine mediates inflammation in Lupus-like mice","volume":"46","author":"Wang","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111106_b0195","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/cei.12840","article-title":"Interleukin (IL)-39 [IL-23p19\/Epstein\u2013Barr virus-induced 3 (Ebi3)] induces differentiation\/expansion of neutrophils in lupus-prone mice","volume":"186","author":"Wang","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"10.1016\/j.clinbiochem.2026.111106_b0200","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1177\/0961203313498799","article-title":"Glucocorticoid downregulates expression of IL-12 family cytokines in systemic lupus erythematosus patients","volume":"22","author":"Qiu","year":"2013","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111106_b0205","first-page":"589","article-title":"Interleukin-35 in autoimmune dermatoses","volume":"17","author":"Xie","year":"2022","journal-title":"Current Concepts."},{"key":"10.1016\/j.clinbiochem.2026.111106_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.675250","article-title":"CD3(+)CD4(+)gp130(+) T cells are associated with worse disease activity in systemic lupus erythematosus patients","volume":"12","author":"Mohd Shukri","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111106_b0215","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MAJ.0000000000000215","article-title":"Decreased interleukin 35 and CD4+EBI3+ T cells in patients with active systemic lupus erythematosus","volume":"348","author":"Ouyang","year":"2014","journal-title":"Am. J. Med. Sci."},{"issue":"5","key":"10.1016\/j.clinbiochem.2026.111106_b0220","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.4049\/jimmunol.160.5.2539","article-title":"Decreased production of TGF-\u03b2 by Lymphocytes from patients with Systemic Lupus Erythematosus1","volume":"160","author":"Ohtsuka","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.clinbiochem.2026.111106_b0225","doi-asserted-by":"crossref","unstructured":"BECKER-MEROK A, EILERTSEN G\u00d8, NOSSENT JC. Levels of Transforming Growth Factor-\u03b2 Are Low in Systemic Lupus Erythematosus Patients with Active Disease. The Journal of Rheumatology. 2010;37(10):2039-45.","DOI":"10.3899\/jrheum.100180"},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111106_b0230","doi-asserted-by":"crossref","first-page":"358","DOI":"10.5606\/ArchRheumatol.2018.6405","article-title":"Serum transforming growth factor-beta 1 level in egyptian systemic lupus erythematosus patients","volume":"33","author":"Menyawi","year":"2018","journal-title":"Arch Rheumatol."},{"key":"10.1016\/j.clinbiochem.2026.111106_b0235","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cyto.2018.04.011","article-title":"Impaired TGF-\u03b2 signaling in patients with active systemic lupus erythematosus is associated with an overexpression of IL-22","volume":"108","author":"Rekik","year":"2018","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111106_b0240","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/08820139.2011.578189","article-title":"Role of Treg cells and TGF-\u03b21 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis","volume":"41","author":"Xing","year":"2012","journal-title":"Immunol. Invest."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111106_b0245","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1038\/s41467-023-39050-y","article-title":"Intrinsic TGF-\u03b2 signaling attenuates proximal tubule mitochondrial injury and inflammation in chronic kidney disease","volume":"14","author":"Kayhan","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111106_b0250","doi-asserted-by":"crossref","DOI":"10.5812\/numonthly.113161","article-title":"Evaluating the serum transforming growth factor-beta 1 level in chronic kidney disease caused by glomerulonephritis","volume":"13","author":"Van Nguyen","year":"2021","journal-title":"Nephro-Urol Mon."},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111106_b0255","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s11255-023-03464-w","article-title":"Blood TGF-\u03b21 and miRNA-21-5p levels predict renal fibrosis and outcome in IgA nephropathy","volume":"55","author":"Bharti","year":"2023","journal-title":"Int. Urol. Nephrol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111106_b0260","doi-asserted-by":"crossref","first-page":"6630","DOI":"10.1038\/s41598-018-24340-z","article-title":"Increased transforming growth factor beta (TGF-\u03b2) and pSMAD3 signaling in a murine model for contrast induced kidney injury","volume":"8","author":"Kilari","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111106_b0265","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1523-1755.2002.00119.x","article-title":"Low TGF-beta1 serum levels are a risk factor for atherosclerosis disease in ESRD patients","volume":"61","author":"Stefoni","year":"2002","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.clinbiochem.2026.111106_b0270","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5500\/wjt.v3.i4.91","article-title":"Role of IL-10 in the progression of kidney disease","volume":"3","author":"Sinuani","year":"2013","journal-title":"World J. Transplant."},{"issue":"291","key":"10.1016\/j.clinbiochem.2026.111106_b0275","first-page":"182","article-title":"Comorbidity status and interleukin-10 levels in end-stage renal disease patients treated with hemodialysis","volume":"49","author":"Shifrisa","year":"2021","journal-title":"Pol. Merkur. Lekarski"},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111106_b0280","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/ndt\/gfaa260","article-title":"Serum levels of IL-6, IL-8 and IL-10 and risks of end-stage kidney disease and mortality","volume":"36","author":"Chen","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"10.1016\/j.clinbiochem.2026.111106_b0285","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2310\/JIM.0b013e3181d88f7b","article-title":"Low level of serum interleukin 27 in patients with systemic lupus erythematosus","volume":"58","author":"Li","year":"2010","journal-title":"J. Investig. Med."},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111106_b0290","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejr.2012.04.002","article-title":"Interleukin-27 and its relation to disease parameters in SLE patients","volume":"34","author":"Gaber","year":"2012","journal-title":"The Egypt. Rheumatol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2026.111106_b0295","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/JLB.3AB0518-180RR","article-title":"The cytokine network type I IFN-IL-27-IL-10 is augmented in murine and human lupus","volume":"106","author":"Lee","year":"2019","journal-title":"J. Leukoc. Biol."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912026000342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912026000342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T07:48:58Z","timestamp":1778399338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912026000342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":59,"alternative-id":["S0009912026000342"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2026.111106","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated IL-27 and altered anti-inflammatory cytokine levels in SLE patients with end-stage renal disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2026.111106","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111106"}}